Filing Details

Accession Number:
0000885590-11-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-13 14:52:17
Reporting Period:
2011-06-09
Filing Date:
2011-06-13
Accepted Time:
2011-06-13 14:52:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1508799 Jr Walden Philip Loberg C/O 7150 Mississauga Road
Mississauga A6 L5N 8M5
Evp, Interim Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2011-06-09 7,500 $52.82 137,565 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.64 to $53.00, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. This number includes 20,694 Performance based Restricted Share Units that were previously reported in Table I.